These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 3643)

  • 21. [Influence of canrenoate potassium (aldactone pro injections) on hemodynamics and myocardial ischemia in experimental myocardial infarct].
    Kötter V; Leitner Ev; Arbeiter G; Cordes R; Schröder R
    Z Kardiol; 1975 Jul; 64(7):672-86. PubMed ID: 1163092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic antagonism of beta-adrenergic blockade in dogs. I. Hemodynamic effects of isoproterenol, dopamine, and epinephrine in acute propranolol administration.
    Avery GJ; Spotnitz HM; Rose EA; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1979 Feb; 77(2):267-76. PubMed ID: 33298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrastive effects of prostaglandin F2 alpha on normal cardiac rhythm and ouabain-induced cardiac arrhythmias in cats: possible neural basis.
    Rao TS; Seth SD; Manchanda SC; Nayar U
    Arch Int Pharmacodyn Ther; 1989; 302():128-44. PubMed ID: 2636814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cardiovascular pharmacology and hemodynamic activity of tazolol, a selective myocardial beta-stimulant.
    Strosberg AM
    Arch Int Pharmacodyn Ther; 1976 Aug; 222(2):200-15. PubMed ID: 10864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiarrhythmic, electrophysiologic and hemodynamic effects of lorcainide.
    Carmeliet E; Janssen PA; Marsboom R; Van Nueten JM; Xhonneux R
    Arch Int Pharmacodyn Ther; 1978 Jan; 231(1):104-30. PubMed ID: 637616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease.
    Atkins CE; Keene BW; McGuirk SM; Sato T
    Am J Vet Res; 1994 Feb; 55(2):262-9. PubMed ID: 8172418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of 8-(3-diethylaminopropyl)-6,6-dimethyl-(2-phenyl-1 H-imidazo(4,5 h))isoquinoline-7,9-(6H)-dione dihydrochloride (AR-LH31) on experimental cardiac arrhythmias in dogs.
    Kerr MJ; Harron DW; Wilson R; Shanks RG
    Arzneimittelforschung; 1985; 35(1A):197-200. PubMed ID: 3838674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of AHR-12234 on cardiac transmembrane action potentials, in situ cardiac electrophysiology and experimental models for arrhythmias.
    Wu KM; Proakis AG; Hunter TL; Shanklin JR
    Arch Int Pharmacodyn Ther; 1989; 301():131-50. PubMed ID: 2624512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of MD770207 (carocainide) on experimental ventricular arrhythmias.
    Pourrias B; Huerta F; Santamaria R; Tisne Versailles J
    Arch Int Pharmacodyn Ther; 1983 May; 263(1):85-102. PubMed ID: 6615084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic and regional hemodynamic, antiarrhythmic and antiischemic effects of bevantolol in anesthetized pigs.
    Verdouw PD; Hartog JM; Saxena PR; Hugenholtz PG
    Am J Cardiol; 1986 Nov; 58(12):8E-16E. PubMed ID: 2878601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of nizofenone on experimental arrhythmia in dogs].
    Nakamura T; Tsumagari T
    Nihon Yakurigaku Zasshi; 1984 Nov; 84(5):441-51. PubMed ID: 6097519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 4th communication: influence on experimentally induced ventricular arrhythmia in dogs.
    Yoshimura A; Yoshioka K; Hino M; Sugawara H; Sakato M; Endoh M
    Arzneimittelforschung; 1999 May; 49(5):420-6. PubMed ID: 10367104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiarrhythmic activity of flestolol, a novel ultra-short-acting beta-adrenoceptor antagonist, in the dog.
    Reynolds RD; Brown BS
    Eur J Pharmacol; 1986 Nov; 131(1):55-66. PubMed ID: 2880726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic and hemodynamic effects of an aminosteroid (Org 3001) in the digitalized dog.
    Remme WJ; Verdouw PD; Hagemeyer F
    Eur J Pharmacol; 1976 Mar; 36(1):189-97. PubMed ID: 1261591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic effects of arotinolol in anesthetized dogs and its affinities for adrenoceptors in vitro.
    Hashimoto H; Asano M; Hayashi T; Oguro K; Takiguchi Y; Nakashima M
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):23-34. PubMed ID: 6202253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular profile of 2-(3,4-diethyoxy-beta-methoxyphenethyl) imino-1-methylpyrrolidine fumarate (McN-2840-46), a preferential atrial anti-arrhythmic agent.
    Hageman WE; Pruss TP
    Arch Int Pharmacodyn Ther; 1979 Feb; 237(2):298-315. PubMed ID: 39528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)].
    Matsubara I; Hashimoto K; Katano Y; Tsukada T; Matsuda H
    Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of bretylium on cardiovascular changes induced by coronary occlusion in the cat.
    Corr PB; Gillis RA
    Eur J Pharmacol; 1975; 33(2):401-4. PubMed ID: 1183484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-arrhythmic action of nadolol, a beta-adrenergic receptor blocking agent.
    Evans DB; Peschka MT; Lee RJ; Laffan RJ
    Eur J Pharmacol; 1976 Jan; 35(1):17-27. PubMed ID: 3420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular and beta-adrenergic blocking effects of timolol.
    Mouillé P; Schmitt H; Cheymol G; Gauter E
    Eur J Pharmacol; 1976 Feb; 35(2):235-43. PubMed ID: 2481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.